Built to answer the questions patients actually ask.
Prescription weight management can be confusing. Brand names are mixed up with molecules, trial results are presented as promises, and medicine prices change quickly. These guides separate the concepts and explain where individual medical judgement is required. Vaya's eligibility process is conducted by a doctor rather than an automated online quiz.
Start with the question you have.
GLP-1 weight loss treatment in India
What GLP-1 means, what studies show, how suitability is assessed and why follow-up matters.
Semaglutide in India: what patients should know
The molecule, how it differs from a brand name, assessment, dosing concepts, safety and costs.
Ozempic vs semaglutide: what is the difference?
Why a brand name and active molecule are not interchangeable terms, particularly as India's market develops.
Who may be eligible for GLP-1 treatment?
BMI, weight-related conditions, medical history and why Vaya uses a doctor-led eligibility process.
How much does GLP-1 treatment cost?
Separate the membership, medicine, dose and clinical support when comparing total treatment costs.
Semaglutide side effects: the patient guide
Common gastrointestinal effects, dose escalation, warning signs and useful questions for a clinician.
Prescription weight management in India
Where medicines fit alongside assessment, nutrition, activity, follow-up and long-term care.
What happens when you stop semaglutide?
What clinical evidence says about weight regain and why maintenance planning should start early.
Eating well during GLP-1 treatment
An India-focused guide to nutrition quality, protein, hydration, meal size and practical everyday food choices.